134 related articles for article (PubMed ID: 4987199)
21. [Safety and immunologic effectiveness of polyantigen from shigellae for oral immunization of monkeys].
Dzhikidze EK; Kavtaradze KN; Raush K; Ketii I; Krasnoproshina LI
Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):73-8. PubMed ID: 413291
[TBL] [Abstract][Full Text] [Related]
22. Genetic determinants of virulence in Shigella and dysenteric strains of Escherichia coli: their involvement in the pathogenesis of dysentery.
Kopecko DJ; Baron LS; Buysse J
Curr Top Microbiol Immunol; 1985; 118():71-95. PubMed ID: 2414072
[No Abstract] [Full Text] [Related]
23. An auxotrophic live oral Shigella flexneri vaccine: development and testing.
Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP; Cam PD; Trach DD; Lindberg AA
Rev Infect Dis; 1991; 13 Suppl 4():S357-61. PubMed ID: 2047663
[TBL] [Abstract][Full Text] [Related]
24. Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.
Mel DM; Terzin AL; Vuksić L
Bull World Health Organ; 1965; 32(5):647-55. PubMed ID: 5294180
[TBL] [Abstract][Full Text] [Related]
25. Studies on vaccination against bacillary dysentery. 5. Studies in Erythrocebus patas.
Mel DM; Cvjetanović B; Felsenfeld O
Bull World Health Organ; 1970; 43(3):431-7. PubMed ID: 4993182
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics of the Shigella flexneri strains isolated from Japanese monkeys (Macaca fuscata)].
Chida T; Okamura N; Taniguchi H; Hondo R
Kansenshogaku Zasshi; 1993 Jun; 67(6):524-7. PubMed ID: 8336006
[TBL] [Abstract][Full Text] [Related]
27. Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis.
Sansonetti PJ; Arondel J
Vaccine; 1989 Oct; 7(5):443-50. PubMed ID: 2683460
[TBL] [Abstract][Full Text] [Related]
28. Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies.
Kärnell A; Stocker BA; Katakura S; Reinholt FP; Lindberg AA
Vaccine; 1992; 10(6):389-94. PubMed ID: 1598787
[TBL] [Abstract][Full Text] [Related]
29. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
[TBL] [Abstract][Full Text] [Related]
30. Protection of adult rabbits and monkeys from lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y.
Ahmed ZU; Sarker MR; Sack DA
Vaccine; 1990 Apr; 8(2):153-8. PubMed ID: 2186582
[TBL] [Abstract][Full Text] [Related]
31. SHIGELLOSIS IN CYNOMOLGUS MONKEYS (MACACA IRUS). II. EXPERIMENTAL INFECTION WITH SHIGELLA FLEXNERI 2A WITH SPECIAL REFERENCES TO CLINICAL AND BACTERIOLOGICAL FINDINGS.
HONJO S; TAKASAKA M; FUJIWARA T; NAKAGAWA M; ANDOO K; OGAWA H; TAKAHASHI R; IMAIZUMI K
Jpn J Med Sci Biol; 1964 Dec; 17():307-19. PubMed ID: 14279864
[No Abstract] [Full Text] [Related]
32. Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens.
Gemski P; Sheahan DG; Washington O; Formal SB
Infect Immun; 1972 Aug; 6(2):104-11. PubMed ID: 4569915
[TBL] [Abstract][Full Text] [Related]
33. Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.
Taylor DN; Phillip DF; Zapor M; Trofa A; Van de Verg L; Hartman A; Bendiuk N; Newland JW; Formal SB; Sadoff JC
Vaccine; 1994 May; 12(6):565-8. PubMed ID: 8036831
[TBL] [Abstract][Full Text] [Related]
34. Regulated Delayed
Su H; Liu Q; Wang S; Curtiss R; Kong Q
Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
[No Abstract] [Full Text] [Related]
35. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
[TBL] [Abstract][Full Text] [Related]
36. Control of Shigella flexneri in Celebes black macaques (Macaca nigra).
Olson LC; Bergquist DY; Fitzgerald DL
Lab Anim Sci; 1986 Jun; 36(3):240-2. PubMed ID: 3523037
[TBL] [Abstract][Full Text] [Related]
37. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
[No Abstract] [Full Text] [Related]
38. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
[TBL] [Abstract][Full Text] [Related]
39. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
40. [Field trials with an oral cell-free vaccine made from Shigella flexneri].
Sergeev VV; Kreĭnin LS; Elkina SI; Kaverina KG; Levina LA
Zh Mikrobiol Epidemiol Immunobiol; 1989 Oct; (10):54-9. PubMed ID: 2692352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
